These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands. Chu W, Tu Z, McElveen E, Xu J, Taylor M, Luedtke RR, Mach RH. Bioorg Med Chem; 2005 Jan 03; 13(1):77-87. PubMed ID: 15582454 [Abstract] [Full Text] [Related]
24. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study. Kossakowski J, Raszkiewicz A, Bugno R, Bojarski AJ. Pol J Pharmacol; 2004 Jan 03; 56(6):843-8. PubMed ID: 15662099 [Abstract] [Full Text] [Related]
25. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. Badarau E, Suzenet F, Bojarski AJ, Fînaru AL, Guillaumet G. Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1600-3. PubMed ID: 19237285 [Abstract] [Full Text] [Related]
26. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells. Heusler P, Newman-Tancredi A, Loock T, Cussac D. Eur J Pharmacol; 2008 Feb 26; 581(1-2):37-46. PubMed ID: 18190908 [Abstract] [Full Text] [Related]
30. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. Neves G, Menegatti R, Antonio CB, Grazziottin LR, Vieira RO, Rates SM, Noël F, Barreiro EJ, Fraga CA. Bioorg Med Chem; 2010 Mar 01; 18(5):1925-35. PubMed ID: 20153652 [Abstract] [Full Text] [Related]
32. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors. Leopoldo M, Lacivita E, Colabufo NA, Niso M, Berardi F, Perrone R. Bioorg Med Chem; 2007 Aug 01; 15(15):5316-21. PubMed ID: 17517509 [Abstract] [Full Text] [Related]
34. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus. Fiorino F, Severino B, De Angelis F, Perissutti E, Magli E, Frecentese F, Esposito A, Massarelli P, Nencini C, Viti B, Santagada V, Caliendo G. Pharmazie; 2009 Sep 01; 64(9):555-64. PubMed ID: 19827295 [Abstract] [Full Text] [Related]
36. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry. Nowak M, Kołaczkowski M, Pawłowski M, Bojarski AJ. J Med Chem; 2006 Jan 12; 49(1):205-14. PubMed ID: 16392805 [Abstract] [Full Text] [Related]
39. Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands. Leopoldo M, Berardi F, Colabufo NA, De Giorgio P, Lacivita E, Perrone R, Tortorella V. J Med Chem; 2002 Dec 19; 45(26):5727-35. PubMed ID: 12477356 [Abstract] [Full Text] [Related]
40. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology. Cussac D, Palmier C, Finana F, De Vries L, Tardif S, Léger C, Bernois S, Heusler P. J Pharmacol Exp Ther; 2009 Oct 19; 331(1):222-33. PubMed ID: 19605522 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]